Live feed
Filing
SC 13G
SC 13G0000902664-23-001720·Axsome Therapeutics, Inc.
Schedule 13G ownership disclosure
Axsome Therapeutics Inc
Security class unavailable · CUSIP: 05464T104
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,980,482
- Percent of class
- 6.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-001720
- Form type
- SC 13G
- Filer
- Axsome Therapeutics, Inc.
- CIK
- CIK 1579428
- Filed
- Feb 14, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership